150 related articles for article (PubMed ID: 1985815)
1. [The diagnosis of thyroid carcinoma].
Sandrock D; Munz DL
Dtsch Med Wochenschr; 1991 Jan; 116(2):77-8. PubMed ID: 1985815
[No Abstract] [Full Text] [Related]
2. [Scintigraphy of medullary carcinoma of the thyroid by new radiopharmaceuticals].
Tada J; Konishi J; Torizuka K; Makimoto K; Miyauchi A
Rinsho Hoshasen; 1984 Sep; 29(9):1043-4. PubMed ID: 6096600
[No Abstract] [Full Text] [Related]
3. New radionuclide tracers for the diagnosis and therapy of medullary thyroid carcinoma.
Hoefnagel CA; Delprat CC; Zanin D; van der Schoot JB
Clin Nucl Med; 1988 Mar; 13(3):159-65. PubMed ID: 2838213
[TBL] [Abstract][Full Text] [Related]
4. Radionuclide imaging in medullary thyroid carcinoma: evaluation of two new radiopharmaceuticals.
Clarke SE; Lazarus CR; Maisey MN
Henry Ford Hosp Med J; 1987; 35(2-3):124-6. PubMed ID: 2826368
[No Abstract] [Full Text] [Related]
5. Poor results with technetium-99m (V) DMS and iodine-131 MIBG in the imaging of medullary thyroid carcinoma.
Hilditch TE; Connell JM; Elliot AT; Murray T; Reed NS
J Nucl Med; 1986 Jul; 27(7):1150-3. PubMed ID: 3014086
[TBL] [Abstract][Full Text] [Related]
6. [The evaluation of 123I-MIBG scintigraphy in medullary thyroid carcinoma (MTC)].
Ahuja S; Koppenhagen K; Ernst H
Strahlenther Onkol; 1990 Nov; 166(11):718-21. PubMed ID: 2260009
[TBL] [Abstract][Full Text] [Related]
7. Uptake of 131I-MIBG by medullary carcinoma of thyroid in familial cases.
Coutris G; Talbot JN; Kabla G; Calmettes C; Milhaud G
Eur J Nucl Med; 1986; 12(2):77-9. PubMed ID: 3732310
[TBL] [Abstract][Full Text] [Related]
8. 131I-MIBG and medullary carcinoma of the thyroid.
Connell JM; Hilditch TE; Elliott A; Semple PF
Lancet; 1984 Dec; 2(8414):1273-4. PubMed ID: 6150300
[No Abstract] [Full Text] [Related]
9. The role of imaging tests in the diagnosis of thyroid carcinoma.
Shulkin BL; Shapiro B
Endocrinol Metab Clin North Am; 1990 Sep; 19(3):523-43. PubMed ID: 2175703
[TBL] [Abstract][Full Text] [Related]
10. Radionuclide imaging in thyroid cancer.
Clarke SE
Nucl Med Commun; 1988 Feb; 9(2):79-82. PubMed ID: 2838774
[No Abstract] [Full Text] [Related]
11. Radioimmunoscintigraphy using iodine-131-anti-CEA monoclonal antibodies and thallium-201 scintigraphy in medullary thyroid carcinoma: a case report.
Zanin DE; van Dongen A; Hoefnagel CA; Bruning PF
J Nucl Med; 1990 Nov; 31(11):1854-5. PubMed ID: 2231001
[TBL] [Abstract][Full Text] [Related]
12. Iodine 131 metaiodobenzylguanidine scintigraphy of medullary carcinoma of the thyroid.
Skowsky WR; Wilf LH
South Med J; 1991 May; 84(5):636-41. PubMed ID: 1852077
[TBL] [Abstract][Full Text] [Related]
13. [Radionuclide imaging using new single-photon tracers].
Tamaki N; Kawamoto M; Takahashi N; Konishi J
Kokyu To Junkan; 1991 Nov; 39(11):1093-100. PubMed ID: 1837935
[No Abstract] [Full Text] [Related]
14. Sipple's syndrome with liver tumors examined by iodine-131 MIBG and technetium-99m(V)-DMSA.
Ohta H; Endo K; Fujita T; Koizumi M; Konishi J; Maki A; Mori K; Ozawa K; Inoue G; Nakano Y
J Nucl Med; 1988 Jun; 29(6):1130-5. PubMed ID: 2897436
[TBL] [Abstract][Full Text] [Related]
15. Localization of hepatic metastases by radiolabelled anti-carcinoembryonic antigen antibody and meta-iodobenzylguanidine in a patient with medullary thyroid carcinoma.
Liewendahl K; Välimäki M; Taavitsainen M
Eur J Nucl Med; 1993 Jun; 20(6):551-4. PubMed ID: 8339736
[TBL] [Abstract][Full Text] [Related]
16. [131-I-MIBG and sporadic medullary carcinoma of the thyroid].
Estopiñán V; de Pablos PL; Hurtado A; de la Calle H
Rev Clin Esp; 1987 Feb; 180(3):174-5. PubMed ID: 3575832
[No Abstract] [Full Text] [Related]
17. Pentavalent [99mTc]DMSA, [131I]MIBG, and [99mTc]MDP--an evaluation of three imaging techniques in patients with medullary carcinoma of the thyroid.
Clarke SE; Lazarus CR; Wraight P; Sampson C; Maisey MN
J Nucl Med; 1988 Jan; 29(1):33-8. PubMed ID: 2826723
[TBL] [Abstract][Full Text] [Related]
18. Metastatic medullary thyroid cancer: localization with iodine-131 metaiodobenzylguanidine.
Sone T; Fukunaga M; Otsuka N; Morita R; Muranaka A; Yanagimoto S; Tomomitsu T; Nakayama H; Harada T
J Nucl Med; 1985 Jun; 26(6):604-8. PubMed ID: 3158726
[TBL] [Abstract][Full Text] [Related]
19. Pentavalent technetium-99m (V)-DMSA uptake in a pheochromocytoma in a patient with Sipple's syndrome.
Adams BK; Fataar A; Byrne MJ; Levitt NS; Matley PJ
J Nucl Med; 1990 Jan; 31(1):106-8. PubMed ID: 1967305
[TBL] [Abstract][Full Text] [Related]
20. Technetium-99m-sestamibi uptake by recurrent Hurthle cell carcinoma of the thyroid.
Balon HR; Fink-BennetT D; Stoffer SS
J Nucl Med; 1992 Jul; 33(7):1393-5. PubMed ID: 1535374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
